Skip to content

Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Home /
About /
News & Rankings /
Valeant to Acquire Bausch & Lomb

Valeant to Acquire Bausch & Lomb

May 28, 2013

Skadden is representing Valeant Pharmaceuticals in its $8.7 billion acquisition of Bausch & Lomb, announced on May 27.

Related Capabilities

Antitrust/Competition
Banking
Capital Markets
Executive Compensation and Benefits
Intellectual Property and Technology
Life Sciences and Health Care
Mergers and Acquisitions
Tax

BACK TO TOP

Contact Us
Legal Notices
Disclaimers
Privacy Statement
Cookies Policy
Technology Overview
Attorney Advertising

Alumni Login
Skadden Foundation

Skadden.com 2024 Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Main Menu

Capabilities
Professionals
Insights

About
Locations
Careers